- Home
- FLS vs ROIV Comparison
FLS vs ROIV Comparison
Compare FLS & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLS | ROIV |
|---|---|---|
| Founded | 1790 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 14.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FLS | ROIV |
|---|---|---|
| Price | $71.28 | $21.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 8 |
| Target Price | ★ $75.50 | $21.94 |
| AVG Volume (30 Days) | 1.5M | ★ 6.5M |
| Earning Date | 10-28-2025 | 11-10-2025 |
| Dividend Yield | ★ 1.17% | N/A |
| EPS Growth | ★ 69.42 | N/A |
| EPS | ★ 3.44 | N/A |
| Revenue | ★ $4,687,417,000.00 | $20,329,000.00 |
| Revenue This Year | $5.80 | N/A |
| Revenue Next Year | $4.04 | $376.94 |
| P/E Ratio | $20.80 | ★ N/A |
| Revenue Growth | ★ 3.19 | N/A |
| 52 Week Low | $37.34 | $8.73 |
| 52 Week High | $74.63 | $22.45 |
Technical Indicators
Market Signals| Indicator | FLS | ROIV |
|---|---|---|
| Relative Strength Index (RSI) | 58.66 | 68.21 |
| Support Level | $70.90 | $20.14 |
| Resistance Level | $74.63 | $21.48 |
| Average True Range (ATR) | 1.81 | 0.66 |
| MACD | -0.22 | -0.02 |
| Stochastic Oscillator | 53.13 | 87.12 |
Price Performance
Historical ComparisonAbout FLS Flowserve Corporation
Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. It has three business segments: FPD for custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and FCD for engineered-to-order and configured-to-order isolation values, control valves, valve automation products and related equipment and Eliminations and All Other.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.